80 participants
A Study of the Safety and Effectiveness of Onasemnogene Abeparvovec (Zolgensma) Intrathecal Injection in Spinal Muscular Atrophy Patients
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2026-08-17
- Start Date:
- 2026-10-30
- Completion:
- 2031-03-31
Conditions
- Spinal Muscular Atrophy
No Results Yet